HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Albert H. Olivencia-Yurvati Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Knott, E. M. Articles by Mallet, R. T. Search for Related Content PubMed PubMed Citation Articles by Knott, E. M. Articles by Mallet, R. T. Related Collections Cardiac - pharmacology

Ann Thorac Surg 2006;81:928-934
© 2006 The Society of Thoracic Surgeons

---

Original article: Cardiovascular

Pyruvate Mitigates Oxidative Stress During Reperfusion of Cardioplegia-Arrested Myocardium

^a Department of Integrative Physiology, University of North Texas Health Science Center, Fort Worth, Texas
^b Department of Surgery, University of North Texas Health Science Center, Fort Worth, Texas

Accepted for publication August 25, 2005.

^_* Address correspondence to Dr Mallet, Department of Integrative Physiology, University of North Texas Health Science Center, 3500 Camp Bowie Blvd, Fort Worth, TX 76107-2699 (Email: malletr{at}hsc.unt.edu).

BACKGROUND: Cardioplegic arrest and reperfusion of the myocardium imposes oxidative stress that could potentially inactivate metabolic enzymes and compromise energy production. This study determined the impact of cardioplegic arrest and reperfusion on activities of several oxidant-sensitive enzymes, and tested whether pyruvate, a natural metabolic fuel and antioxidant, mitigates oxidant stress, protects enzymes, and bolsters myocardial energy state after reperfusion.

METHODS: In situ swine hearts were arrested for 60 minutes with 4:1 blood:crystalloid cardioplegia, and then reperfused for 3 minutes with cardioplegia-free blood with or without approximately 12 mM pyruvate. Tissue metabolites and enzyme activities were measured in left ventricular myocardium snap frozen at 45 minutes of arrest and 3 minutes of reperfusion.

RESULTS: The 8-isoprostane content, a measure of lipid peroxidation, sharply increased upon reperfusion, coincident with a 70% decline in redox state of the intracellular antioxidant glutathione. Aconitase and glucose 6-phosphate dehydrogenase activities fell during arrest; creatine kinase and phosphofructokinase were inactivated upon reperfusion. Pyruvate suppressed 8-isoprostane formation, maintained glutathione redox state, and enhanced phosphocreatine phosphorylation potential, a measure of myocardial energy state, during reperfusion. Pyruvate reactivated creatine kinase and aconitase, which are at least partially mitochondrial enzymes, but did not protect the cytosolic enzymes glucose 6-phosphate dehydrogenase and phosphofructokinase.

CONCLUSIONS: Administration of pyruvate upon reperfusion after cardioplegic arrest mitigates oxidative stress, protects mitochondrial enzymes and increases myocardial energy state. These results support therapeutic application of pyruvate-enhanced reperfusion to prevent cardiac injury after cardioplegic arrest.

This article has been cited by other articles:

				A. K. Olson, O. M. Hyyti, G. A. Cohen, X.-H. Ning, M. Sadilek, N. Isern, and M. A. Portman Superior cardiac function via anaplerotic pyruvate in the immature swine heart after cardiopulmonary bypass and reperfusion Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2315 - H2320. [Abstract] [Full Text] [PDF]